1.            Bishara, A., Brautbar, C., Cereb, N. & Israel, S. Identification of 33 novel HLA alleles in Arab potential bone marrow donors. HLA 95, 128–130 (2020).

2.            Bishara, A. et al. High resolution HLA allele and haplotype frequencies for Arab donors in the Hadassah bone marrow donor registry. Hum. Immunol. 80, 823–827 (2019).

3.            Aboukaoud, M., Israel, S., Brautbar, C. & Eyal, S. Genetic Basis of Delayed Hypersensitivity Reactions to Drugs in Jewish and Arab Populations. Pharm. Res. 35, (2018).

4.            Maggio, N. et al. Causative Drugs of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Israel. J. Clin. Pharmacol. 57, 823–829 (2017).

5.            Levy, J., Amar, A., Brautbar, C., Slavin, S. & Kapelushnik, J. Transient recovery of endogenous immune function following haploidentical peripheral stem cell transplantation in a patient with severe combined immunodeficiency without evidence of engraftment. Acta Paediatr. Int. J. Paediatr. 89, 248–250 (2000).

6.            Israel, S. et al. Genetic risk factors for antiepileptic drug–induced hypersensitivity reactions in Israeli populations. Epilepsia 57, e205–e209 (2016).

7.            Fernandez Vina, M. A. et al. Tracking human migrations by the analysis of the distribution of HLA alleles, lineages and haplotypes in closed and open populations. Philos. Trans. R. Soc. B Biol. Sci. 367, 820–829 (2012).

8.            Klitz, W. et al. Genetic differentiation of Jewish populations. Tissue Antigens 76, 442–458 (2010).

9.            Benedek, G. et al. Opposing effects of the HLA-DRB10301-DQB10201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel. Genes Immun. 11, 423–431 (2010).

10.          Benedek, G. et al. Effect of polymorphism in insulin locus and HLA on type 1 diabetes in four ethnic groups in Israel. Tissue Antigens 73, 33–38 (2009).

11.          Gazit, R. et al. Immunological assessment of familial tinea corporis. J. Eur. Acad. Dermatology Venereol. 22, 871–874 (2008).

12.          Thomson, G. et al. Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: A meta-analysis. Tissue Antigens 70, 110–127 (2007).

13.          Israel, S., Weinrib, L., Weintrob, N., Miller, K. & Brautbar, C. Distribution of the V281L mutation of the CYP21 gene in Israeli congenital adrenal hyperplasia patients and its association with HLA-B14. Pediatr. Endocrinol. Rev. 3, 447–450 (2006).

14.          Bishara, A., Brautbar, C., Zamir, G., Eid, A. & Safadi, R. Impact of HLA-C and Bw epitopes disparity on liver transplantation outcome. Hum. Immunol. 66, 1099–1105 (2005).

15.          De Santis, D. et al. Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants. Tissue Antigens 65, 519–528 (2005).

16.          Martínez-Borra, J. et al. The region of 150 kb telometic to HLA-C is associated with psoriasis in the jewish population. J. Invest. Dermatol. 125, 928–932 (2005).

17.          Zung, A. et al. Type 1 diabetes in Jewish Ethiopian immigrants in Israel: HLA class II immunogenetics and contribution of new environment. Hum. Immunol. 65, 1463–1468 (2004).

18.          Bishara, A. et al. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. Tissue Antigens 63, 204–211 (2004).

19.          Bishara, A. et al. Is presensitization relevant to liver transplantation outcome? Hum. Immunol. 63, 742–750 (2002).

20.          Peled, N., Amar, A., Peled, E., Brautbar, C. & Pillar, G. DRB1*1502-DQB1*0601-DQA1*0103 and DRB1*04-DQB1*0302 in Jewish hypersomnolent patients. Sleep Med. 3, 267–270 (2002).

21.          Weintrob, N. et al. Decreased cortisol secretion in nonclassical 21-hydroxylase deficiency before and during glucocorticoid therapy. J. Pediatr. Endocrinol. Metab. 15, 985–991 (2002).

22.          Bishara, A., Mohana, N., Nagler, A. & Brautbar, C. Mechanisms of interactions between Natural Killer cells and fibroblasts in graft versus host disease. Eur. J. Immunogenet. 28, 263 (2001).

23.          Bishara, A., Brautbar, C., Eid, A., Sherman, L. & Safadi, R. Killer inhibitory receptor mismatching and liver transplantation outcome. Transplant. Proc. 33, 2908 (2001).

24.          Bishara, A., Admon, D., Sherman, L. & Brautbar, C. Detection of anti-HLA antibodies by ELISA: Relevance to heart transplantation. Transplant. Proc. 33, 2909 (2001).

25.          González, S. et al. Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population. Hum. Immunol. 62, 632–638 (2001).

26.          Klitz, W., Brautbar, C., Schito, A. M., Barcellos, L. F. & Oksenberg, J. R. Evolution of the CCR5 δ32 mutation based on haplotype variation in Jewish and Northern European population samples. Hum. Immunol. 62, 530–538 (2001).

27.          Nagler, A. et al. Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation. Exp. Hematol. 29, 362–370 (2001).

28.          Kwon, O. J. et al. Immunogenetics of HLA class II in Israeli Ashkenazi Jewish, Israeli non-Ashkenazi Jewish, and in Israeli Arab IDDM patients. Hum. Immunol. 62, 85–91 (2001).

29.          Hodak, E. et al. Mycosis fungoides: HLA class II associations among Ashkenazi and non-Ashkenazi Jewish patients. Br. J. Dermatol. 145, 974–980 (2001).

30.          Weintrob, N. et al. Type 1 diabetes environmental factors and correspondence analysis of HLA class II genes in the Yemenite Jewish community in Israel. Diabetes Care 24, 650–653 (2001).

31.          Israel, S. & Brautbar, C. A molecular method of diagnosi of Congenital Adrenal Hyperplasia. Harefuah 139, 429–433 (2000).

32.          Tsafrir, A. et al. Alloreactivity of umbilical cord blood mononuclear cells: Specific hyporesponse to noninherited maternal antigens. Hum. Immunol. 61, 548–554 (2000).

33.          Meir, M. B. et al. Neonatal sclerosing cholangitis associated with autoimmune phenomena. J. Pediatr. Gastroenterol. Nutr. 30, 332–334 (2000).

34.          Elchalal, U. et al. Postpartum umbilical cord blood collection for transplantation: A comparison of three methods. Am. J. Obstet. Gynecol. 182, 227–232 (2000).

35.          Weintrob, N. et al. Genotype-phenotype associations in non-classical steroid 21-hydroxylase deficiency. Eur. J. Endocrinol. 143, 397–403 (2000).

36.          Hurley, C. K. et al. A special report: Histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Tissue Antigens 53, 394–406 (1999).

37.          Mora, B. et al. Strong linkage disequilibrium of TAP1*0301 and TAP2D alleles with the HLA A1-B35-DRB1*1104-DQA1*0103-DQB1*0603 extended haplotype in Ashkenazi Jews. Eur. J. Immunogenet. 26, 331–335 (1999).

38.          Bishara, A., Brautbar, C., Cohen, I. & Nagler, A. Positivity in a modified mixed leukocyte reaction test correlates with molecular HLA-C disparity in prediction of unrelated bone marrow transplantation outcome. Hum. Immunol. 60, 833–839 (1999).

39.          Amar, A. et al. Molecular analysis of HLA class II polymorphisms among different ethnic groups in Israel. Hum. Immunol. 60, 723–730 (1999).

40.          Naparstek, E. et al. Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies. Exp. Hematol. 27, 1210–1218 (1999).

41.          Bishara, A., Sherman, L., Freidlander, M., Eid, A. & Brautbar, C. Comparison of ELISA QuickScreen and PRA-STAT with CDC-AHG for PRA determination. Transplant. Proc. 31, 1878 (1999).

42.          Bishara, A., Sherman, L., Raizman, S., Popovtzer, M. & Brautbar, C. Negative response to noninherited maternal antigens confirmed by ELISA. Transplant. Proc. 31, 1879–1880 (1999).

43.          Gonzalez, S. et al. The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis. Arthritis Rheum. 42, 1010–1016 (1999).

44.          Karni, A. et al. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel. Mult. Scler. 5, 410–415 (1999).

45.          Varadi, G. et al. Graft-versus-lymphoma effect after allogeneic peripheral blood stem cell transplantation for primary central nervous system lymphoma. Leuk. Lymphoma 34, 185–190 (1999).

46.          Shai, R. et al. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum. Mol. Genet. 8, 639–644 (1999).

47.          Hurley, C. K. et al. A special report: Histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Hum. Immunol. 60, 347–360 (1999).

48.          Amar, A. et al. Genetic variation of three tetrameric tandem repeats in four distinct Israeli ethnic groups. J. Forensic Sci. 44, 983–986 (1999).

49.          Hurley, C. K. et al. Histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors: Report from The World Marrow Donor Association. Bone Marrow Transplant. 24, 119–121 (1999).

50.          Shinar, Y. et al. Analysis of allelic association between D6S461 marker and multiple sclerosis in Ashkenazi and Iraqi Jewish patients. J. Mol. Neurosci. 11, 265–269 (1998).

51.          Kwon, O. J. et al. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews. Arch. Neurol. 56, 555–560 (1999).

52.          Elkayam, O. et al. Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena. Am. J. Med. 105, 484–487 (1998).

53.          Israel, S. et al. Hla class II immunogenetics of IDDM in Yemenite Jews. Hum. Immunol. 59, 728–733 (1998).

54.          Nagler, A., Bishara, A., Brautbar, C. & Barak, V. Dysregulation of inflammatory cytokines in unrelated bone marrow transplantation. Cytokines, Cell. Mol. Ther. 4, 161–167 (1998).

55.          Frucht-Pery, J. et al. Limbal cell autograft transplantation for severe ocular surface disorders. Graefe’s Arch. Clin. Exp. Ophthalmol. 236, 582–587 (1998).

56.          Bishara, A. et al. Enhanced lymphoid cell recovery after bone marrow transplantation: Correlation with the presence of costimulatory antibodies in serum. Exp. Hematol. 26, 580–587 (1998).

57.          Bishara, A. et al. Cytokine production in human mixed leukocyte reactions performed in serum-free media. J. Immunol. Methods 215, 187–190 (1998).

58.          Mehrian, R. et al. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum. 41, 596–602 (1998).

59.          Bishara, A., Nagler, A. & Brautbar, C. Cellular test used to determine compatibility between bone marrow donor and recipient in HLA in identical twins. Harefuah 134, 471–476 (1998).

60.          Slavin, S. et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 91, 756–763 (1998).

61.          Kauschansky, A. et al. D-penicillamine-induced pancreatic islet autoantibody production is independent of the immunogenetic background: A lesson from patients with Wilson’s disease. Clin. Immunol. Immunopathol. 89, 279–283 (1998).

62.          Freier, S. et al. Hereditary CD4+ T lymphocytopenia. Arch. Dis. Child. 78, 371–372 (1998).

63.          Or, R. et al. Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantation. J. Immunother. 21, 447–453 (1998).

64.          Amar, A. et al. An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB1*0201. Int. J. Neuropsychopharmacol. 1, 41–44 (1998).

65.          Frucht-Pery, J., Siganos, C. S., Solomon, A., Brautbar, C. & Zauberman, H. Conjunctival limbal cell transplantation [clct] for ocular surface disorders. Investig. Ophthalmol. Vis. Sci. 38, (1997).

66.          Bishara, A., Brautbar, C., Cohen, J. & Naglar, A. Prediction of transplant related complications post unrelated bone marrow transplantation (bmt) by modified mixed leukocyte culture (mlr) assay. Exp. Hematol. 25, 823 (1997).

67.          Del Carmen Theiler, G. et al. HLA-B35 alleles in 282 individuals from nine different populations of Europe and Israel. Immunogenetics 46, 524–528 (1997).

68.          Bishara, A. et al. Pretransplant crossmatching: An individualized process. Transplant. Proc. 29, 2708–2710 (1997).

69.          Bishara, A., Brautbar, C. & Nagler, A. HLA and graft-versus-host disease: A population-based study of HLA phenotypes of Jewish and Arabic bone marrow transplanted patients in Israel. Leuk. Res. 21, 111–118 (1997).

70.          Karni, A. et al. Reactivity of T cells from seronegative patients with myasthenia gravis to T cell epitopes of the human acetylcholine receptor. Neurology 48, 1638–1642 (1997).

71.          Israel, S. et al. Two new DR2 alleles: DRB1*1607 identified in an Ashkenazi Jewish family and DRB1*15022 found in a single Caucasian donor. Tissue Antigens 49, 173–175 (1997).

72.          Yinnon, A. M. et al. Invasive cryptococcosis in a family with epidermodysplasia verruciformis and idiopathic CD4 cell depletion. Clin. Infect. Dis. 25, 1252–1253 (1997).

73.          Nagler, A., Brautbar, C., Slavin, S. & Bishara, A. Bone marrow transplantation using unrelated and family related donors: The impact of HLA-C disparity. Bone Marrow Transplant. 18, 891–897 (1996).

74.          Friedlaender, M. M., Azem, O., Rubinger, D. & Brautbar, C. Effect of human recombinant erythropoietin therapy on panel reactive antibodies in chronic dialysis patients. Isr. J. Med. Sci. 32, 730–736 (1996).

75.          Zisman, E. et al. Peptide analogs to pathogenic epitopes of the human acetylcholine receptor a subunit as potential modulators of myasthenia gravis. Proc. Natl. Acad. Sci. U. S. A. 93, 4492–4497 (1996).

76.          Slavin, S. et al. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood 87, 2195–2204 (1996).

77.          Bishara, A., Brautbar, C. & Nagler, A. Interaction between natural killer (NK) cells and the major histocompatibility system. Harefuah 130, 322–326 (1996).

78.          Bishara, A. et al. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT). Exp. Hematol. 23, 1667–1675 (1995).

79.          Frisan, T. et al. Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin’s disease. Blood 86, 1493–1501 (1995).

80.          Elchalal, U. et al. Human umbilical cord blood as a source of hematopoietic progenitor cells for transplantations. Harefuah 128, 776–780 (1995).

81.          Gofrit, O. et al. Kidney transplantation from living, related donors. Harefuah 128, 201-204,264 (1995).

82.          Varadi, G., Elchalal, U., Brautbar, C. & Nagler, A. Human umbilical cord blood for hematopoietic progenitor cells transplantation. Leuk. Lymphoma 20, 51–58 (1995).

83.          Kwon, O. J. et al. HLA class II analysis in Jewish Israeli narcoleptic patients. Hum. Immunol. 44, 199–202 (1995).

84.          Zisman, E. et al. Binding of peptides of the human acetylcholine receptor α-subunit to HLA class II of patients with myasthenia gravis. Hum. Immunol. 44, 121–130 (1995).

85.          Vardy, D. A. et al. Castleman’s disease associated pemphigus. A form of paraneoplastic pemphigus. J. Eur. Acad. Dermato. Venereol. 4, 273–279 (1995).

86.          Rave-Harel, N. et al. CFTR haplotype analysis reveals genetic heterogeneity in the etiology of congenital bilateral aplasia of the vas deferens. Am. J. Hum. Genet. 56, 1359–1366 (1995).

87.          Roitberg‐Tambur, A. et al. Comparative analysis of HLA polymorphism at the serologic and molecular level in Moroccan and Ashkenazi Jews. Tissue Antigens 46, 104–110 (1995).

88.          Evron, E. et al. Correlation between gold‐induced enterocolitis and the presence of the HLA‐DRB 1*0404 allele. Arthritis Rheum. 38, 755–759 (1995).

89.          Naparstek, E. et al. T‐cell‐depleted allogeneic bone marrow transplantation for acute leukaemia using Campath‐1 antibodies and post‐transplant administration of donor’s peripheral blood lymphocytes for prevention of relapse. Br. J. Haematol. 89, 506–515 (1995).

90.          Matzner, Y. et al. Identical HLA class II alleles predispose to drug-triggered and idiopathic pemphigus vulgaris. Acta Derm. Venereol. 75, 12–14 (1995).

91.          Lewin, N. et al. Detection of two epstein‐barr‐virus (EBV)‐carrying leukemic cell clones in a patient with chronic lymphocytic leukemia (CLL). Int. J. Cancer 61, 159–164 (1995).

92.          Engelhard, D. et al. Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: A 5-year prospective study. Bone Marrow Transplant. 16, 565–570 (1995).

93.          Brautbar, C., Safirman, C. & Roitberg-Tambur, A. HLA polymorphism at the molecular level and its role in organ and bone marrow transplantation. Harefuah 126, 737–742 (1994).

94.          Fridkis-Hareli, M. et al. Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells - Specificity and promiscuity. Proc. Natl. Acad. Sci. U. S. A. 91, 4872–4876 (1994).

95.          Segal, R., Elkayam, O., Caspi, D., Brautbar, C. & Yaron, M. Familial presentation of Early osteoarthritis with a HLA-DR association. Clin. Rheumatol. 13, 139–141 (1994).

96.          Nagler, A. et al. Interleukin-3 in combination with granulocyte-macrophage-colony-stimulating factor following bone marrow transplantation in a radiation accident victim. Med. Oncol. 11, 27–28 (1994).

97.          Shapira, L. et al. Sequential manifestation of different forms of early-onset periodontitis. A case report. J. Periodontol. 65, 631–635 (1994).

98.          Shapira, L., Eizenberg, S., Sela, M. N., Soskolne, A. & Brautbar, H. HLA A9 and B15 are associated with the generalized form, but not the localized form, of early-onset periodontal diseases. J. Periodontol. 65, 219–223 (1994).

99.          Roitberg-Tambur, A. et al. HLA polymorphism in Moroccan Jewry. Hum. Immunol. 40, 61–67 (1994).

100.        Bishara, A. et al. Prediction by a modified mixed leukocyte reaction assay of graft-versus-host disease and graft rejection after allogeneic bone marrow transplantation. Transplantation 57, 1474 (1994).

101.        Smith, A. G. et al. Two new DR52‐associated alleles, DRB1*1111 and *1312, identified by PCR/SSOP and confirmed by DNA sequencing. Tissue Antigens 44, 52–56 (1994).

102.        Roitberg-Tambur, A. et al. Do specific pockets of HLA-C molecules predispose Jewish patients to psoriasis vulgaris? J. Am. Acad. Dermatol. 31, 964–968 (1994).

103.        González-Roces, S. et al. Molecular analysis of HLA-B27 haplotypes in caucasoids frequencies of B27-Cw in jewish and spanish populations. Hum. Immunol. 41, 127–134 (1994).

104.        Tzfoni, E. E., Scherman, L., Battat, S. & Brautbar, H. No HLA antigen is significant in classic Kaposi’s sarcoma. J. Am. Acad. Dermatol. 28, 118–119 (1993).

105.        Amar, A., Battat, S., Anteby, S. O., Brautbar, C. & Reubinoff, B. E. INVASIVE SQUAMOUS CELL CARCINOMA OF THE CERVIX: IS HLA‐DQ A DISEASE MARKER IN JEWISH PATIENTS? Int. J. Immunogenet. 20, 327–333 (1993).

106.        Friedmann, A. & Brautbar, C. Immune response genes and autoimmune diseases. Isr. J. Med. Sci. 29, 145–150 (1993).

107.        Eilam, O., Goldin, E., Shouval, D., Gimon, T. & Brautbar, C. Sclerosing cholangitis associated with Crohn’s disease and autoimmune haemolytic anaemia. Postgrad. Med. J. 69, 656–658 (1993).

108.        Roitberg-Tambur, A. et al. Molecular analysis of HLA class II genes in primary sjögren’s syndrome. A study of Israeli Jewish and Greek Non-Jewish patients. Hum. Immunol. 36, 235–242 (1993).

109.        Bishara, A. et al. A 2‐DAY MLR PROCEDURE FOR MARROW DONOR SELECTION FOR ALLOGENEIC BONE MARROW TRANSPLANTATION. Int. J. Immunogenet. 20, 289–292 (1993).

110.        Papa, M. et al. Autoimmune mechanisms in thromboangiitis obliterans (Buerger’s disease): The role of tobacco antigen and the major histocompatibility complex. Surgery 111, 527–531 (1992).

111.        Amar, A. et al. SEROLOGICAL AND MOLECULAR ANALYSIS OF HLA IN ISRAELI PRIMARY SCLEROSING CHOLANGITIS PATIENTS. Int. J. Immunogenet. 19, 295–302 (1992).

112.        Meiner, Z., Zlotogorski, A. & Brautbar, C. Pemphigus associated with multiple sclerosis. Clin. Exp. Dermatol. 17, 217 (1992).

113.        Friedlaender, M. M. et al. Kidney transplantation in Jerusalem, 1972-89. Isr. J. Med. Sci. 28, 1–8 (1992).

114.        Foldes, J., Shamir, S., Brautbar, C., Schermann, L. & Menczel, J. HLA-D antigens and Paget’s disease of bone. Clin. Orthop. Relat. Res. 266, 301–303 (1991).

115.        Elkayam, O. et al. Familial Erythema Nodosum. Arthritis Rheum. 34, 1177–1179 (1991).

116.        Fernandez-Viña, M. A. et al. Alleles at four HLA class II loci determined by oligonucleotide hybridization and their associations in five ethnic groups. Immunogenetics 34, 299–312 (1991).

117.        Gao, X. et al. A variant of HLA–DR4 determines susceptibility to rheumatoid arthritis in a subset of Israeli Jews. Arthritis Rheum. 34, 547–551 (1991).

118.        Elkayam, O. et al. Regulatory T cell activity specific to human type II and III collagens in rheumatoid arthritis. J. Rheumatol. 18, 516–521 (1991).

119.        Bishara, A., Kedar, E., Leshem, B., Rosenkovitch, E. & Brautbar, C. A short human and mouse mlr assay utilizing lymphokine (Il-2, il-3) secretion as an early activation event. Transplantation 51, 1104–1109 (1991).

120.        Roitberg-Tambur, A. et al. Immunogenetics of HLA class II genes in primary Sjogren’s syndrome in Israeli Jewish patients. Isr. J. Med. Sci. 26, 677–681 (1990).

121.        Bishara, A. & Brautbar, C. Detection and identification of HLA antigens in dried spleens by means of enzyme linked immunosorbent assay (ELISA). Forensic Sci. Int. 45, 97–105 (1990).

122.        Zlotogorski, A., Weinrauch, L. & Brautbar, C. Familial alopecia areata: No linkage with HLA. Tissue Antigens 36, 40–41 (1990).

123.        Bishara, A., Sharon, R., Kohn, G., Nelken, D. & Brautbar, C. Determination of surface bound and shed HLA antigens of amniotic cells by ELISA. Isr. J. Med. Sci. 26, 34–38 (1990).

124.        Scharf, S. J., Freidmann, A., Steinman, L., Brautbar, C. & Erlich, H. A. Erratum: Specific HLA-DQB and HLA-DRB1 alleles confer susceptibility to pemphigus vulgaris (Proc. Natl. Acad. Sci. USA (86, 6215-6219)). Proc. Natl. Acad. Sci. U. S. A. 86, 10023 (1989).

125.        Bishara, A. & Brautbar, C. A sensitive and specific ELISA using monoclonal capture antibodies for the detection of HLA antigens in blood stains. J. Immunol. Methods 120, 99–103 (1989).

126.        Tzfoni, E., Brautbar, C. & Friedman, A. Pemphigus vulgaris immunogenetics. J. Am. Acad. Dermatol. 21, 594 (1989).

127.        Slavin, S. et al. The use of total lymphoid irradiation (TLI) for prevention of rejection of T-lymphocyte depleted bone marrow allografts in non-malignant hematological disorders. Transplant. Proc. 21, 3053–3054 (1989).

128.        Scharf, S. J., Freidmann, A., Steinman, L., Brautbar, C. & Erlich, H. A. Specific HLA-DQB and HLA-DRB1 alleles confer susceptibility to pemphigus vulgaris. Proc. Natl. Acad. Sci. U. S. A. 86, 6215–6219 (1989).

129.        Or, R. et al. Bone marrow transplantation with T-cell depleted allografts for the treatment of severe beta thalassemia major. Prog. Clin. Biol. Res. 309, 217–222 (1989).

130.        Segal, R. et al. Common variable immunodeficiency: A family study and therapeutic trial with cimetidine. J. Allergy Clin. Immunol. 84, 753–761 (1989).

131.        Leshem, B., Cohen, I., Sherman, L., Brautbar, C. & Kedar, E. Typing of HLA class II and class I antigens using PHA-activated, IL-2-propagated T lymphocytes. J. Immunol. Methods 111, 131–135 (1988).

132.        Bishara, S. A., Bishara, A. H. & Brautbar, C. Zonal variation of HLA expression on human cornea epithelium. Cornea 7, 252–256 (1988).

133.        Brocke, S. et al. In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patient with myasthenia gravis and relation to HLA class II genes. J. Clin. Invest. 82, 1894–1900 (1988).

134.        Sinha, A. A. et al. A newly characterized HLA DQβ allele associated with pemphigus vulgaris. Science (80-. ). 239, 1026–1029 (1988).

135.        Bishara, A., Nelken, D. & Brautbar, C. Differential Expression of HLA Class-I Antigens on B and T Lymphocytes Obtained from Human Lymphoid Tissues. Immunobiology 177, 76–81 (1988).

136.        Torsteinsdottir, S., Brautbar, C., Klein, G., Klein, E. & Masucci, M. G. Differential expression of hla antigen of HLA anigens on human B‐cell lines of normal and malignant origin: A consequence of immune surveillance or a phenotypic vestige of the progenitor cells? Int. J. Cancer 41, 913–919 (1988).

137.        Friedlaender, M. M. et al. Successful HLA-A, B, C, DR and DQ-identical sibling kidney transplantation with mixed lymphocyte culture reactivity and positive B-cell cross-match. Isr. J. Med. Sci. 24, 119–122 (1988).

138.        Amar, A., Zohar, M., Tiwari, J. & Brautbar, C. HLA and schizophrenia in Israel. Isr. J. Med. Sci. 24, 28–31 (1988).

139.        Tomer, Y., Zamir, R., Brautbar, C., Pinkhas, J. & Weinberger, A. HLA antigens in patients with Heberden’s nodes. Isr. J. Med. Sci. 24, 24–27 (1988).

140.        Wilner, A. et al. Narcolepsy-cataplexy in Israeli Jews is associated exclusively with the HLA DR2 haplotype A study at the serological and genomic level. Hum. Immunol. 21, 15–22 (1988).

141.        Slavin, S. et al. Bone marrow transplantation in beta-thalassemia major with prevention of graft-vs-host disease. Birth Defects Orig. Artic. Ser. 23, 313–316 (1988).

142.        OKSENBERG, J. R., MOR‐YOSEF, S., EZRA, Y. & BRAUTBAR, C. Antigen Presenting Cells in Human Decidual Tissue: III. Role of Accessory Cells in the Activation of Suppressor Cells. Am. J. Reprod. Immunol. Microbiol. 16, 151–158 (1988).

143.        Mozes, E., Mendlovic, S., Bentwich, Z., Brautbar, C. & Shoenfeld, Y. T-cell-helper factors in autoimmunity. Isr. J. Med. Sci. 24, 355–358 (1988).

144.        Scharf, S. J. et al. HLA class II allelic variation and susceptibility to pemphigus vulgaris. Proc. Natl. Acad. Sci. U. S. A. 85, 3504–3508 (1988).

145.        Masucci, M. G. et al. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Proc. Natl. Acad. Sci. U. S. A. 84, 4567–4571 (1987).

146.        Milwidsky, A. et al. Absence of HLA linkage in familial hypogonadotropic hypogonadism. J. Reprod. Med. Obstet. Gynecol. 32, 96–98 (1987).

147.        Chajek-Shaul, T. et al. HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behcet’s syndrome. Am. J. Med. 83, 666–672 (1987).

148.        Tishler, M., Brautbar, C., Battat, S., Dayan, M. & Mozes, E. Analysis of the antigen specific helper T cell function and HLA‐DR of Israeli patients with rheumatoid arthritis (RA). Tissue Antigens 30, 229–234 (1987).

149.        Katz, J., Goultschin, J., Benoliel, R. & Brautbar, C. Human leukocyte antigen (HLA) DR4. Positive association with rapidly progressing periodontitis. J. Periodontol. 58, 607–610 (1987).

150.        Slavin, S. et al. Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders. Transplant. Proc. 19, 2614–2615 (1987).

151.        Cohen, N. et al. HLA-Dw clusters associated with DR4 in Israeli Jews and the definition of a new DR4 associated Dw subtype: Dw"SHA". Hum. Immunol. 19, 179–188 (1987).

152.        BISHARA, A. et al. Human Leukocyte Antigens (HLA) Class I and Class II on Sperm Cells Studied at the Serological, Cellular, and Genomic Levels. Am. J. Reprod. Immunol. Microbiol. 13, 97–103 (1987).

153.        Zeliszewski, D. et al. Functional relationships between HLA-DR2-short/FJO, DB9, and AZH as defined by DR- and DQ-restricted influenza-specific cloned T cells. Immunogenetics 26, 107–110 (1987).

154.        Szafer, F. et al. Detection of disease-specific restriction fragment length polymorphisms in pemphigus vulgaris linked to the DQw1 and DQw3 alleles of the HLA-D region. Proc. Natl. Acad. Sci. U. S. A. 84, 6542–6545 (1987).

155.        Torsteinsdottir, S. et al. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 83, 5620–5624 (1986).

156.        Brautbar, C. et al. Immunogenetics of juvenile chronic arthritis in Israel. J. Rheumatol. 13, 1072–1075 (1986).

157.        Tishler, M., Brautbar, C., Yaron, M., Dayan, M. & Mozes, E. Association between HLA-DR4 and production of collagen-specific antibodies in Israeli patients with rheumatoid arthritis. Isr. J. Med. Sci. 22, 771–773 (1986).

158.        Segal, R. et al. Analysis of antigen specific T cell helper function in the first degree relatives of patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 66, 52–60 (1986).

159.        Shalev, Y., Bentwich, Z., Katz, D., Brautbar, C. & Mozes, E. Antigen specific immune response potential and HLA typing of Israeli patients with thyroid autoimmune diseases (TAD). Clin. Exp. Immunol. 64, 255–260 (1986).

160.        Cohen, N. et al. Polymorphism of the HLA DR1 haplotype in the Israeli population investigated at the serological, cellular, and genomic levels. Immunogenetics 23, 252–259 (1986).

161.        Torsteinsdottir, S. et al. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones. Cell. Immunol. 98, 453–466 (1986).

162.        Cohen, N., Brautbar, C., Font, M.-P., Dausset, J. & Cohen, D. HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters. Immunogenetics 23, 84–89 (1986).

163.        Katz, D. et al. Genetic control of HLA-linked immune responsiveness to (H,G)-AL. Hum. Immunol. 15, 75–84 (1986).

164.        Persitz, E., Oksenberg, J. & Brautbar, C. The HLA system and habitual spontaneous abortions. Harefuah 110, 33–36 (1986).

165.        OKSENBERG, J. R. et al. Antigen‐Presenting Cells in Human Decidual Tissue. Am. J. Reprod. Immunol. Microbiol. 11, 82–88 (1986).

166.        Brautbar, C. et al. Immunogenetics of rheumatoid arthritis in Israel. Tissue Antigens 28, 8–14 (1986).

167.        OKSENBERG, J. R. & BRAUTBAR, C. In Vitro Suppression of Murine Blastocysts Growth by Sera From Women With Reproductive Disorders. Am. J. Reprod. Immunol. Microbiol. 11, 118–124 (1986).

168.        Ben-Chetrit, E., Brautbar, C. & Rubinow, A. HLA antigens in Reiter’s syndrome in Israeli patients. J. Rheumatol. 12, 964–966 (1985).

169.        Shalev, Y., Bentwich, Z., Katz, D., Brautbar, C. & Mozes, E. (T,G)-A-L specific immune response potential and HLA typing of Israeli patients with systemic lupus erythematosus. Clin. Exp. Immunol. 60, 355–362 (1985).

170.        OKSENBERG, J. R., PERSITZ, E. & BRAUTBAR, C. Cellular Immunity in Human Milk. Am. J. Reprod. Immunol. Microbiol. 8, 125–129 (1985).

171.        Hurwitz, A. et al. Combined 21- and 11β-hydroxylase deficiency in familial congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 60, 631–638 (1985).

172.        Suez, D. et al. HLA-linked immune responsiveness to (T,G)-A-L: A family study. Hum. Immunol. 13, 219–234 (1985).

173.        Persitz, E. et al. Histoincompatibility in couples with unexplained infertility. Fertil. Steril. 43, 733–738 (1985).

174.        Slavin, S. et al. Elimination of graft versus host disease in matched allogeneic leukemic transplant recipients using CAMPATH-1. Adv. Exp. Med. Biol. 186, 813–818 (1985).

175.        Karp, M. et al. Unusual association of insulin-dependent diabetes mellitus with congenital myasthenia gravis and autoimmune thyroid disease. Isr. J. Med. Sci. 20, 1078–1081 (1984).

176.        Torsteinsdottir, S. et al. T lymphocyte culture established by repeated stimulation with the autologous lymphoblastoid line. MHC class II restricted interactions with B blasts. Mol. Biol. Med. 2, 285–299 (1984).

177.        Waldmann, H. et al. ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1). Lancet 324, 483–486 (1984).

178.        Friedlaender, M. M. et al. Ethnic differences in kidney graft survival. Isr. J. Med. Sci. 20, 186–190 (1984).

179.        Oksenberg, J. R. et al. Mixed lymphocyte reactivity nonresponsiveness in couples with multiple spontaneous abortions. Obstet. Gynecol. Surv. 39, 165–167 (1984).

180.        Amar, A., Mickelson, E., Hansen, J. A., Shalev, Y. & Brautbar, C. HLA-Dw"SHY": A new lymphocyte defined specificity associated with HLA-DRw10. Hum. Immunol. 11, 143–149 (1984).

181.        Amar, A. et al. HLA determinants in psoriasis vulgaris in Israel. Tissue Antigens 24, 247–249 (1984).

182.        Levene, C., Steinberg, A. G., Friedlander, Y., Brautbar, C. & Cohen, T. Genetic polymorphisms among Bukharan and Georgian Jews in Israel. Am. J. Med. Genet. 19, 623–641 (1984).

183.        Dahan, S., Slater, P. E., Cooper, M., Brautbar, C. & Ashkenazi, A. Coeliac disease in the Rehovot-Ashdod region of Israel: Incidence and ethnic distribution. J. Epidemiol. Community Health 38, 58–60 (1984).

184.        AMAR, A. et al. Is predisposition to pemphigus vulgaris in Jewish patients mediated by HLA‐Dw10 and DR4? Tissue Antigens 23, 17–22 (1984).

185.        BRAUTBAR, C., ZLOTOGORA, J., LAUFER, N., COHEN, T. & ALBERT, E. D. Do identical HLA‐DR3 genes convey susceptibility to celiac disease and insulin dependent diabetes mellitus? Tissue Antigens 23, 58–60 (1984).

186.        BISHARA, A., NELKEN, D., BONAVIDA, B. & BRAUTBAR, C. Enzyme‐linked immunosorbent assay for determination of HLA: gene dose effect. Tissue Antigens 23, 284–289 (1984).

187.        Oksenberg, J. R., Persitz, E., Amar, A. & Brautbar, C. Maternal-paternal histocompatibility: Lack of association with habitual abortions. Fertil. Steril. 42, 389–395 (1984).

188.        Cohen, N., Amar, A., Oksenberg, J. R. & Brautbar, C. HLA‐D clusters associated with DR2 and the definition of HLA‐D“AZH”: a new DR2 related HLA‐D specificity in Israel. Tissue Antigens 24, 1–9 (1984).

189.        Mickelson, E. et al. HLA‐DR2 and DR4 further defined by two new HLA‐D specificities (HTC) derived from Israeli Jewish donors: comparative study in Caucasian, Korean, Eskimo and Israeli populations. Tissue Antigens 24, 197–205 (1984).

190.        Cohen, N., Amar, A. & Brautbar, C. Definition of a new DR2 short associated HLA‐D specificity with the Ninth Histocompatibility Workshop reagents. Tissue Antigens 24, 184–186 (1984).

191.        Schlesinger, M., Ilfeld, D. N., Zamir, R. & Brautbar, C. Familial Mediterranean fever: no linkage with HLA. Tissue Antigens 24, 65–66 (1984).

192.        Cohen, N., Shaw, S., Amar, A., Oksenberg, J. & Brautbar, C. HLA‐linked SB antigens in Israel: Population study, analysis of homozygous typing cells and generation of local SB reagents. Tissue Antigens 24, 113–120 (1984).

193.        Naparstek, Y., Abrahamov, A., Cohen, T. & Brautbar, C. Familial hereditary thrombocytopenia and HLA. Am. J. Hematol. 17, 113–116 (1984).

194.        Bishara, A., Brautbar, C., Marbach, A., Bonavida, B. & Nelken, D. Enzyme-linked immunosorbent assay for HLA determination on fresh and dried lymphocytes. J. Immunol. Methods 62, 265–271 (1983).

195.        Naparstek, E., Amar, A. & Brautbar, C. Suppression of mixed lymphocyte reactivity by cellular and humoral factors in aplastic anemia―both before and after bone marrow transplantation. Transplantation 36, 365–369 (1983).

196.        Wernet, P., Shaw, S., Brautbar, C., Westphal, E. & Pawelec, G. SB Types of HLA-D homozygous typing cells. Immunogenetics 18, 547–551 (1983).

197.        Katz, D., Brautbar, C., Bentwich, Z. & Mozes, E. Genetically regulated human (T,G)-AL specific helper T cell replacing factors possess HLA-DR and Vh determinants. Hum. Immunol. 7, 217–227 (1983).

198.        Plesser, Y. M., Markson, Y., Weiss, D. W., Brautbar, C. & Doljanski, F. Shedding of histocompatibility and blood group antigenic determinants from human epithelial cells and fibroblasts in culture. Cell. Mol. Biol. 29, 227–236 (1983).

199.        Brautbar, C. et al. Study of a family with Cerebrotendinous Xanthomatosis: No HLA linkage, but an informative recombination between HLA—B and Bf. Tissue Antigens 21, 233–237 (1983).

200.        Oksenberg, J. et al. HLA‐D “BG” in Israel: A Japanese related allele population and family study. Tissue Antigens 21, 271–280 (1983).

201.        Granat, M., Amar, A., Mor-Yosef, S., Brautbar, C. & Schenker, J. G. Familial gonadal germinative failure: Endocrine and human leukocyte antigen studies. Fertil. Steril. 40, 215–219 (1983).

202.        Oksenberg, J. R. et al. Mixed lymphocyte reactivity nonresponsiveness in couples with multiple spontaneous abortions. Fertil. Steril. 39, 525–529 (1983).

203.        Persitz, E. et al. Histocompatibility antigens, mixed lymphocyte reactivity and severe preeclampsia in Israel. Gynecol. Obstet. Invest. 16, 283–291 (1983).

204.        Levo, Y., Tur-Kaspa, R., Shouval, D., Brautbar, C. & Eliakim, M. Histocompatibility antigens and cell-mediated immunity in carriers of hepatitis B virus; A study of a family. J. Clin. Lab. Immunol. 9, 105–107 (1982).

205.        Brautbar, C. et al. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis. Isr. J. Med. Sci. 18, 631–634 (1982).

206.        Strehler, B. L. et al. Hayflick-NIH settlement [3]. Science (80-. ). 215, 240–242 (1982).

207.        Oksenberg, J. R., Amar, A., Cohen, N., Cohen, T. & Brautbar, C. HLA-DR,D recombination in a kidney transplant recipient. Hum. Immunol. 4, 47–53 (1982).

208.        Brautbar, C. et al. HLA‐D typing in multiple sclerosis: Israelis tested with European homozygous typing cells. Tissue Antigens 19, 189–197 (1982).

209.        AMAR, A., OKSENBERG, J., COHEN, N., COHEN, I. & BRAUTBAR, C. HLA‐D locus in Israel. Characterization of 14 local HTC’s and a population study. Tissue Antigens 20, 198–207 (1982).

210.        Kodo, H., Brautbar, C., Colvin, M., Gale, R. P. & Bonavida, B. Selective inhibitory effects of 4-hydroperoxycyclophosphamide (4-HCY) on T and B functions in man. Int. J. Immunopharmacol. 4, 366 (1982).

211.        Hacham‐Zadeh, S., Brautbar, C., Cohen, C. A. & Cohen, T. HLA and alopecia areata in Jerusalem. Tissue Antigens 18, 71–74 (1981).

212.        Brautbar, C. et al. Histocompatibility Determinants in Israeli Jewish Patients with Coeliac Disease: Population and Family Study. Tissue Antigens 17, 313–322 (1981).

213.        Brautbar, C. et al. HLA in a Selective Aldosterone Biosynthetic Defect due to Type 2 Corticosterone Methyl‐Oxidase Deficiency. Tissue Antigens 17, 212–216 (1981).

214.        Cohen, I., Yemini, M., Wexler, M. R. & Brautbar, H. Prolonged survival of allogeneic mouse skin grafts following preservation. Isr. J. Med. Sci. 16, 628–630 (1980).

215.        Brautbar, C., Cohen, T. & Nelken, D. Disputed Parentage Due to Exchanged Babies Solved by HLA. Vox Sang. 39, 322–326 (1980).

216.        Cohen, T. et al. Genetic studies on Cochin Jews in Israel: 1. Population data, blood groups, isoenzymes, and HLA determinants. Am. J. Med. Genet. 6, 61–73 (1980).

217.        Rosenmann, A., Schumert, Z., Theodor, R., Cohen, T. & Brautbar, C. Amniotic 17-α hydroxyprogesterone and HLA typing for the prenatal diagnosis of 21-α hydroxylase deficiency - congenital adrenal hyperplasia. Am. J. Med. Genet. 6, 295–300 (1980).

218.        Steinberg, A. G. et al. Genetic studies on Cochin Jews in Israel: 2. Gm and Inv Data - polymorphism for Gm3 and for Gm1,17,21 without Gm(26). Am. J. Med. Genet. 6, 75–81 (1980).

219.        Brautbar, C. et al. HLA–DRw4 in Pemphigus Vulgaris Patients in Israel. Tissue Antigens 16, 238–243 (1980).

220.        Brautbar, C. et al. No Linkage between HLA and Congenital Adrenal Hyperplasia Due to 11-β-Hydroxylase Deficiency. N. Engl. J. Med. 300, 205–206 (1979).

221.        Ticho, U., Cohen, T. & Brautbar, C. Absence of association between HLA antigens and primary open angle glaucoma in Israel. Isr. J. Med. Sci. 15, 124–127 (1979).

222.        Gazit, E. et al. HLA Polymorphism in Israel*: 1. Jews of Polish Extraction. Tissue Antigens 11, 195–200 (1978).

223.        Zamir, R., Brautbar, C., Mizrachi, Y., Yehoshua, H. & Gazit, E. HLA Polymorphism in Israel: 4. Israeli Jews originating from Rumania. Tissue Antigens 11, 213–216 (1978).

224.        Brautbar, C., Chajek, T., Ben‐Tuvia, S., Lamm, L. & Cohen, T. A Genetic Study of Behqet Disease in Israel. Tissue Antigens 11, 113–120 (1978).

225.        Gazit, E. et al. HLA Polymorphism in Israel: 7. The Babylonian Jews. Tissue Antigens 11, 226–229 (1978).

226.        Brautbar, C., Zamir, R., Efter, T. & Gazit, E. HLA Polymorphism in Israel: 2. Israeli Jews originating from Russia. Tissue Antigens 11, 201–205 (1978).

227.        Bonné‐Tamir, B. et al. HLA Polymorphism in Israel: 9. An Overall Comparative Analysis. Tissue Antigens 11, 235–250 (1978).

228.        Gazit, E., Zamir, R., Efter, T., Zfat, Z. & Brautbar, C. HLA Polymorphism in Israel: 5. The Moroccan Jews. Tissue Antigens 11, 217–220 (1978).

229.        Brautbar, C., Lahana, E., Alter, M., Jørgensen, F. & Lamm, L. Lack of Association between HLA-DW2 and Multiple Sclerosis in Israeli Jewish Patients. N. Engl. J. Med. 296, 1537–1538 (1977).

230.        Brautbar, C. et al. Histocompatibility Determinants in Israeli Jewish Patients with Multiple Sclerosis. Tissue Antigens 10, 291–302 (1977).

231.        Galili, U., Brautbar, C. & Schlesinger, M. Association between HLA Determinants and Complement Receptors on Human Lymphocytes. Tissue Antigens 10, 99–107 (1977).

232.        Brautbar, C., Porat, S., Nelken, D., Gabriel, K. R. & Cohen, T. HLA B27 and ankylosing spondylitis in the Israeli population. J. Rheumatol. Suppl. 3, 24–32 (1977).

233.        Pellegrino, M. A., Ferrone, S., Brautbar, C. & Hayflick, L. Changes in HL-A antigen profiles on SV40-transformed human fibroblasts. Exp. Cell Res. 97, 340–345 (1976).

234.        Bentwich, R., Cohen, R. & Brautbar, C. T and B blocking factors in Hodgkin’s disease. Adv. Exp. Med. Biol. 66, 685–690 (1976).

235.        Eldor, A. et al. Aplastic anemia following acute viral hepatitis associated with hypogammaglobulinemia: attempted treatment by bone marrow transplantation (Hebrew). Harefuah 89, 105-107+144 (1975).

236.        Bentwich, Z., Cohen, R. & Brautbar, C. Proceedings: T and B blocking factors in Hodgkin’s disease. Isr. J. Med. Sci. 11, 1382 (1975).

237.        Brautbar, C. et al. Expression of HL A antigens on cultured human fibroblasts infected with mycoplasmas. J. Immunol. 111, 1783–1789 (1973).

238.        Brautbar, C. et al. Fate of HL-A antigens in aging cultured human diploid cell strains. II. Quantitative absorption studies. Exp. Cell Res. 78, 367–375 (1973).

239.        Brautbar, C., Payne, R. & Hayflick, L. Fate of HL-A antigens in aging cultured human diploid cell strains. Exp. Cell Res. 75, 31–38 (1972).

240.        Cohen, I., Brautbar, H. & Nelken, D. Passive immunological enhancement of skin allografts in rats. Transplantation 11, 135–137 (1971).

241.        Brautbar, C., Nelken, D., Boss, J. H. & Superstine, E. Autoimmune graft rejection. II. Rejection of skin autotransplants in rats sensitized with homologous and heterologous skin preparations. Int. Arch. Allergy Appl. Immunol. 39, 98–104 (1970).

242.        Nelken, D., Brautbar, C. & Boss, J. H. Autograft rejection, temporary transplantation of autografts to allogeneic and xenogeneic hosts within and without diffusion chambers. Experientia 25, 1080 (1969).

243.        Brautbar, C., Nelken, D. & Boss, J. H. Autograft rejection: I. Effect of prior transplantation to allogeneic and xenogeneic hosts. Transplantation 8, 121–126 (1969).

244.        Brautbar, C., Nelken, D. & Boss, J. H. Autoimmune graft rejection. Int. Arch. Allergy Immunol. 35, 323–329 (1969).

245.        Brautbar, C. & Nelken, D. Accelerated rejection of rat allografts after the rejection of rabbit skin grafts. Clin. Exp. Immunol. 2, 691–695 (1967).

246.        Brautbar, C. & Nelken, D. Shortened survival of rat allografts after the rejection of xenografts. Isr. J. Med. Sci. 3, 580–581 (1967).